Skin Booster Injection with Needle Increased Collagen and Elastin Levels

Name: Skin Booster Injection with Needle Increased Collagen and Elastin Levels
Brand: QUFU HI-TECH TRADING CO., LTD.
SKU: 2123910312

Shandong, ChinaQUFU HI-TECH TRADING CO., LTD.

US$25.00

2-9 Pieces

US$23.00

10-49 Pieces

US$22.00

50-99 Pieces

US$20.00

100+ Pieces

Product specifications

packaging

Sample price:US$30.00/piece.Request sample

Product profile

Customization

Available

Supply Type

OEM/ODM

Suitable for

Adult

Model NO.

2ml

Form

Gel

Brand Name

Reforteha Skin Booster

Ingredient

Hyaluronic Acid

Color

Transparent

Treatment

2 Sessions,1 Month Apart

Model No.

1ml

Volume

1ml/2ml/3ml/5ml

Shelf Life

6 Month

Cross-Linked Agent

No Bdde

Certificate

CE ISO

Transport Package

1syringe 2bd Needles/Box

Specification

19× 7.5× 2.5

Trademark

ReforteHA

Origin

Shandong, China

Production Capacity

30000/Month

Company profile

Fast DeliveryFull CustomizationFlexible CustomizationHigh Repeat Buyers Choice

QUFU HI-TECH TRADING CO., LTD.

Shandong, China

Business Type: Manufacturer/FactoryExport Year: 2010-08-01Nearest Port: Qingdao, Shanghai, ShenzhenAverage Response Time: ≤8.41hTerms of Payment: T/T, PayPal, Western Union, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, FCA, CPT

AI-Powered supplier vetting

SummaryThe supplier demonstrates medical-device-related management certifications through ISO 13485 and GMP, has reported dermal filler production capacity, and offers broad customization, ODM, and OEM services. It reports new products within the past year and has 11–20 years of total R&D engineer experience, supporting its development capability. Service operations include inventory availability, complaint-handling and corrective-action procedures with records, and participation in Dubai Derma. However, it does not provide 3D software design, overseas agents or branches, overseas warehouses, or overseas showrooms. Financial records are identified for 2021–2023, but no performance figures are provided. Raw-material traceability, outsourcing controls, and quality-assurance status remain unclear. Customer-case evidence is limited to OEM service for well-known brands without named cases.

CertificationsThe supplier reports holding ISO 13485 and GMP certifications. These certifications are directly relevant to quality and manufacturing controls for medical-related products, although the provided information does not include certificate validity periods or scopes.

After-Sales capabilityThe supplier has a clear complaint-handling procedure with followed records and a clear corrective and preventive action procedure with records. It also reports in-stock service capability, but lacks overseas agents or branches, overseas warehouses, and overseas showrooms, which limits local overseas service infrastructure.

R&D capabilityThe supplier reports new products within the past year, 11–20 years of total R&D engineer experience, ODM capability, OEM service for well-known brands, and an available SDK. These indicators support active product development and collaborative design capability, although 3D software design services are explicitly unavailable.

Production capacityReported production information includes 850,000 dermal filler pieces annually, inventory capability, and peak- and off-season lead times within 15 working days. The supplier also reports four qualified service suppliers, while outsourcing procedures and contracts are unknown; overall capacity is evidenced but operational controls for outsourced production remain incomplete.

Customization capabilityThe supplier explicitly offers customization from samples, designs, minor customization, flexible customization, and full customization, as well as ODM and OEM services. This indicates broad product customization capability, although it does not extend to 3D software design services.